Tarlatamab in DLL3-Expressing Tumors Including NEN • ClinicalTrials.gov： NCT06788938 • Dr. Goldman10просмотров8 дней назад
The Latest on Immunotherapy for Neuroendocrine Cancer - 2025 NCF Event - Dec 11 202515просмотров9 дней назад
Bridging Inequities in Neuroendocrine Cancer Care： A Conversation with Dr. Udhayvir Grewal • 20256просмотров9 дней назад
The Latest in NET • Tools, Trials, and Treatments Explained • Dr. Chauhan • 20254просмотра9 дней назад
The Latest Advances in Neuroendocrine Cancer： An Update with Dr. Udhayvir Grewal • 20256просмотров9 дней назад
The Latest in High-Grade Neuroendocrine Carcinoma (NEC)： A Conversation with Dr. Chauhan • 20254просмотра9 дней назад
Update on Cabozantinib Neuroendocrine Cancer Foundation Interview with Dr. Aman Chauhan • 20259просмотров9 дней назад
Study of 225Ac-ABD147 to Establish Optimal Dose • ClinicalTrials.gov： NCT06736418 • Dr. Chauhan5просмотров22 дня назад
(CAREFNDR) Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen•NCT0708705410просмотров22 дня назад
